Spectrum Asset Management (California)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.57M Sell
22,804
-3,471
-13% -$520K 0.99% 32
2026
Q1
$4.01M Sell
26,275
-13
-0% -$1.99K 1.28% 23
2025
Q4
$3.62M Buy
26,288
+120
+0.5% +$15.7K 1.21% 29
2025
Q3
$3.36M Buy
26,168
+1,513
+6% +$185K 1.18% 31
2025
Q2
$2.98M Buy
+24,655
New +$2.78M 1.3% 31

Other funds holding NVS

Spectrum Asset Management (California)'s NVS Position: Q2 2026 in Review

Spectrum Asset Management (California) reduced its Novartis (NVS) stake by 13% in Q2 2026, selling an estimated $520K and leaving 22,804 shares worth $3.57M. The position accounts for 0.99% of the portfolio, ranked #32.

Spectrum Asset Management (California) first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. The position peaked at $4.01M in Q1 2026. 1,618 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Spectrum Asset Management (California) held 22,804 shares of Novartis worth $3.57M as of Q2 2026.
  • Spectrum Asset Management (California) sold 3,471 Novartis shares in Q2 2026, an estimated $520K.
  • Novartis made up 0.99% of Spectrum Asset Management (California)'s portfolio in Q2 2026, its #32 holding.
  • Spectrum Asset Management (California) first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • Spectrum Asset Management (California)'s Novartis position peaked at $4.01M in Q1 2026.
  • 1,618 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Spectrum Asset Management (California)'s 13F filing for Q2 2026, filed 3 Aug 2026.